Smart pill to check gut health in colon inflammation and cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a smart pill that measures gut health in people with colon inflammation (ulcerative colitis) or colon cancer. It aims to see if the pill can help doctors better understand how the gut is working during treatment or before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a bowel movement at least once every 48 hours
- If you have ulcerative colitis, you must have moderate to severe active disease starting or changing treatment
- If you have colon cancer, you must be scheduled for surgery and the tumor should not be blocking the bowel
- You must not have a pacemaker or other electronic implant
- You must not be pregnant, breastfeeding, or trying to get pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a smartphone app and activity tracker to monitor how people with Crohn's disease, ulcerative colitis, or unspecified IBD feel day to day. It may help doctors better understand and manage your condition through digital health data.
This study tests whether a non-invasive device (like a wearable or smartphone app) can measure inflammation in people with active IBD. It aims to make monitoring easier and less uncomfortable than traditional methods.
This trial tests whether a camera capsule can detect problems in the large intestine when certain gut bacteria are found in the blood. If you have one of these bacteria and are stable enough for the exam, it might help identify the source of the infection.
This study looks at whether stool tests, combined with a special camera test of the colon, can help find early signs of colon changes in people who have had ulcerative colitis for a long time. It aims to improve how we monitor for any serious changes like cancer.
This study uses simple breath tests to measure changes in your gut during dietary treatment for ulcerative colitis. It may help doctors understand why some people respond better to dietary changes and guide future treatment decisions.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
Hear when a new Colorectal Cancer (CRC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.